T-cell polarizing factors
T-cell polarizing factors. T-cell receptors (TCRs) on the naïve T-cell (Th0) bind to antigen presented by antigen-presenting cells (APCs), which leads to the tyrosine phosphorylation of immuno-receptor tyrosine-based activation motifs (ITAMs). This induces the release of adaptor molecules [e.g. linker for activated T cells (LAT), protein kinase C], which results in the sequential activation of GTPases, mitogen-activated protein kinases (MAPKs) and activator protein-1 (AP-1), which induces T-cell proliferation (a) Upon T-cell activation, phospholipase C (PLC) activity is induced, which breaks down membrane-associated phosphatidylinositol-bis-phosphate (PIP2) into the intracellular second messengers inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 induces calcium release, which results in cytokine expression, and DAG stimulates protein kinase C and causes T-cell activation through the MAPK pathway. The type of cytokine expressed is the most important factor influencing the phenotype of the developing T cells. Cytokines bind to their receptors on Th0 cells and activate Janus kinase and signal transducers and activators of transcription (JAK-STAT) pathways. Different combinations of JAK and STAT molecules are generated in response to different cytokines and induce different signaling cascades, which drive the development of the specific T-cell phenotype. Interferon-γ (IFN-γ) and interleukin (IL)-12 induce JAK1/2 and STAT1/3/4 to stimulate T-bet and further IFN-γ production, resulting in a T helper type-1 (Th1) response, whereas IL-4 triggers JAK1/3 and STAT6 to activate GATA-3 and a T helper type-2 (Th2) response. Features of Th1 cells: Th1 cytokines; increased Ca2+, IFN-γ and IL-12; decreased protein kinase C and GATA-3 (IFN-γ and IL-12 mediated). Features of Th2 cells: Th2 cytokines; increased monocytic chemotactic protein-1 (MCP-1) and protein kinase C; decreased Ca2+. CTLA-4, cytotoxic T lymphocyte antigen-4; NFAT, nuclear factor of activated T cells.
Publication
Immunological decision-making: how does the immune system decide to mount a helper T-cell response?. (2008) Gerard E Kaiko, et al. Immunology. 2008 Mar;123(3):326-338. Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CD28, | CD28 | ncbigene_symbol | CD28 | 940 |
| Homo sapiens | Primates | CD3 | CD3 | famplex_relations | CD247 | 919 |
| Homo sapiens | Primates | CD3 | CD3 | famplex_relations | CD3D | 915 |
| Homo sapiens | Primates | CD3 | CD3 | famplex_relations | CD3E | 916 |
| Homo sapiens | Primates | CD3 | CD3 | famplex_relations | CD3G | 917 |
| Homo sapiens | Primates | CD4 | CD4 | ncbigene_symbol | CD4 | 920 |
| Homo sapiens | Primates | LAT | LAT | ncbigene_symbol | LAT | 27040 |
| Homo sapiens | Primates | LAT | LAT | ncbigene_synonym | ORC3 | 23595 |
| Homo sapiens | Primates | LAT | LAT | ncbigene_synonym | SPNS1 | 83985 |
| Homo sapiens | Primates | JAK2 | JAK2 | ncbigene_symbol | JAK2 | 3717 |
| Homo sapiens | Primates | L-12 | L12 | ncbigene_synonym | RPL12 | 6136 |
| Homo sapiens | Primates | L-12 | L12 | ncbigene_synonym | RSL1D1 | 26156 |
| Homo sapiens | Primates | L-12 | L12 | ncbigene_synonym | IGKV1-5 | 28299 |
| Homo sapiens | Primates | CTLA-4 | CTLA-4 | ncbigene_synonym | CTLA4 | 1493 |
| Homo sapiens | Primates | JAK1 | JAK1 | ncbigene_symbol | JAK1 | 3716 |
| Homo sapiens | Primates | JAK1/3 | JAK3 | ncbigene_symbol | JAK3 | 3718 |
| Homo sapiens | Primates | tyk2 | TYK2 | ncbigene_symbol | TYK2 | 7297 |
| Homo sapiens | Primates | STAT3 | STAT3 | ncbigene_symbol | STAT3 | 6774 |
| Homo sapiens | Primates | PLC | PLC | ncbigene_synonym | HSPG2 | 3339 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCE1 | 51196 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCZ1 | 89869 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCB1 | 23236 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCB2 | 5330 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCB3 | 5331 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCB4 | 5332 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCD1 | 5333 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCD3 | 113026 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCD4 | 84812 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCG1 | 5335 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCG2 | 5336 |
| Homo sapiens | Primates | TAP- | TAP | ncbigene_synonym | FLNB | 2317 |
| Homo sapiens | Primates | TAP- | TAP | ncbigene_synonym | USO1 | 8615 |
| Homo sapiens | Primates | TAP- | TAP | ncbigene_synonym | NXF1 | 10482 |
| Homo sapiens | Primates | TAP- | TAP | ncbigene_synonym | SEC14L2 | 23541 |
| Homo sapiens | Primates | TAP- | TAP | famplex_relations | TAP1 | 6890 |
| Homo sapiens | Primates | TAP- | TAP | famplex_relations | TAP2 | 6891 |
| Homo sapiens | Primates | TAP- | TAP | famplex_relations | ABCB9 | 23457 |
| Homo sapiens | Primates | T-bet | T-BET | ncbigene_synonym | TBX21 | 30009 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC1 | 4772 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC2 | 4773 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC3 | 4775 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC4 | 4776 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFAT5 | 10725 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|